Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
14 Febbraio 2025 - 4:42PM
Edgar (US Regulatory)
Exhibit 1
JOINT FILING
AGREEMENT
The
undersigned agree that this Schedule 13G Amendment No. 3 dated February 14, 2025 relating to the Common Stock, par value $0.001 per share
of Kezar Life Sciences, Inc., shall be filed on behalf of the undersigned.
| |
Avidity Partners Management LP
By Avidity Partners Management (GP)
LLC, its general partner
By: /s/ Michael Gregory |
| |
Title:
Managing Member |
| |
Avidity Partners Management (GP) LLC
By: /s/ Michael Gregory |
| |
Title:
Managing Member |
| |
Avidity Capital Partners Fund (GP) LP
By Avidity Capital Partners (GP) LLC,
its general partner
By: /s/ Michael Gregory |
| |
Title:
Managing Member |
| |
Avidity Capital Partners (GP) LLC
By: /s/ Michael Gregory |
| |
Title:
Managing Member |
| |
Avidity Master Fund LP
By Avidity Capital Partners Fund (GP)
LP, its general partner
By: Avidity Capital Partners (GP) LLC,
its general partner
By: /s/ Michael Gregory |
| |
Title:
Managing Member |
| |
David Witzke
By: /s/ David Witzke |
| |
Michael Gregory
By: /s/ Michael Gregory |
| |
|
Grafico Azioni Kezar Life Sciences (NASDAQ:KZR)
Storico
Da Gen 2025 a Feb 2025
Grafico Azioni Kezar Life Sciences (NASDAQ:KZR)
Storico
Da Feb 2024 a Feb 2025
